Other Information
−Removed: Rule 10b5-1 Director and Officer Trading Arrangements
−Removed: During the three months ended October 27, 2023, certain of our officers and directors adopted “Rule 10b5-1 trading arrangements ,” intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act as follows.
−Removed: On September 20, 2023 , Brett Wall , Executive Vice President and President Neuroscience Portfolio , adopted a Rule 10b5-1 trading plan.
−Removed: Wall’s trading plan provides for the sale of 4,997 shares of the Company’s common stock at market on December 19, 2023 prior to the plan's December 22, 2023 termination date.
−Removed: Medtronic plc 2024 Employee Stock Purchase Plan
+Added: Not applicable.
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
10 unchanged sentences
Medtronic plc
−Removed: November 30, 2023 /s/ Jennifer M.
+Added: February 27, 2024 /s/ Jennifer M.
Senior Vice President, Global Controller and Chief Accounting Officer (Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.